6-97178453-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001350599.2(MMS22L):c.2669G>A(p.Arg890Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000389 in 1,543,254 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001350599.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MMS22L | NM_001350599.2 | c.2669G>A | p.Arg890Gln | missense_variant | 18/25 | ENST00000683635.1 | NP_001337528.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MMS22L | ENST00000683635.1 | c.2669G>A | p.Arg890Gln | missense_variant | 18/25 | NM_001350599.2 | ENSP00000508046.1 | |||
MMS22L | ENST00000275053.8 | c.2669G>A | p.Arg890Gln | missense_variant | 18/25 | 2 | ENSP00000275053.4 | |||
MMS22L | ENST00000369251.6 | c.2549G>A | p.Arg850Gln | missense_variant | 16/23 | 2 | ENSP00000358254.2 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 151988Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000952 AC: 2AN: 210144Hom.: 0 AF XY: 0.0000175 AC XY: 2AN XY: 114342
GnomAD4 exome AF: 0.00000359 AC: 5AN: 1391266Hom.: 0 Cov.: 27 AF XY: 0.00000434 AC XY: 3AN XY: 690600
GnomAD4 genome AF: 0.00000658 AC: 1AN: 151988Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74244
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 27, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at